Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -2.45 is 983% below its 4-year average of -0.23, near the low end of its 4-year range (-11.54–27.90).
As of the fiscal period ended Tuesday, June 30, 2026. 3.67% above its 12-month average of -2.54.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -2.45.
DEBT TO EQUITY RATIO
-2.45
DEBT TO EQUITY RATIO AVG TTM
-2.54
DEBT TO EQUITY RATIO AVG 3Y
-2.06
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.67%
CURRENT VS 3Y AVG
-18.92%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13
median of 641 covered companies
CURRENT VS SECTOR MEDIAN
-1982.40%
vs the sector median at left
Indivior Pharmaceuticals Inc
Market Cap
$4.44B
Debt to Equity Ratio
-2.45
TTM Avg
-2.54
3Y Avg
-2.06
5Y Avg
N/A
Market Cap
$4.45B
Debt to Equity Ratio
2.87
TTM Avg
0.86
3Y Avg
0.57
5Y Avg
0.43
Market Cap
$4.36B
Debt to Equity Ratio
0.01
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.01
Market Cap
$4.30B
Debt to Equity Ratio
0.10
TTM Avg
0.07
3Y Avg
0.07
5Y Avg
0.07
Market Cap
$4.61B
Debt to Equity Ratio
0.27
TTM Avg
0.44
3Y Avg
1.89
5Y Avg
1.89
Market Cap
$4.65B
Debt to Equity Ratio
1.01
TTM Avg
0.92
3Y Avg
0.87
5Y Avg
0.94
Market Cap
$4.70B
Debt to Equity Ratio
0.14
TTM Avg
0.24
3Y Avg
0.29
5Y Avg
0.27
Market Cap
$4.15B
Debt to Equity Ratio
0.03
TTM Avg
0.06
3Y Avg
0.06
5Y Avg
0.05
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.44B | -2.45 | -2.54 | -2.06 | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | 2.87 | 0.86 | 0.57 | 0.43 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | 0.01 | 0.01 | 0.01 | 0.01 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.30B | 0.10 | 0.07 | 0.07 | 0.07 |
| BillionToOne, Inc. (BLLN)vs › | $4.61B | 0.27 | 0.44 | 1.89 | 1.89 |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 1.01 | 0.92 | 0.87 | 0.94 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 0.14 | 0.24 | 0.29 | 0.27 |
| LivaNova PLC (LIVN)vs › | $4.16B | 0.27 | 0.45 | 0.47 | 0.46 |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.15B | 0.03 | 0.06 | 0.06 | 0.05 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | 0.04 | 0.04 | 0.07 | 0.05 |
Debt/Equity
-2.45
Current Ratio
0.84
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -2.45 |
| 2026-03-31 | -3.53 |
| 2025-12-31 | -3.58 |
| 2025-09-30 | -1.72 |
| 2025-06-30 | -1.42 |
| 2025-03-31 | -1.29 |
| 2024-12-31 | -1.08 |
| 2024-09-30 | -1.70 |
| 2024-06-30 | -2.32 |
| 2024-03-31 | 27.90 |
| 2023-12-31 | -1.48 |
| 2023-09-30 | -11.54 |
| 2023-06-30 | 2.40 |
| 2023-03-31 | 3.88 |
| 2022-12-31 | 5.40 |
| 2022-09-30 | 1.22 |
| 2022-06-30 | 1.22 |
| 2022-03-31 | 1.22 |
| 2021-12-31 | 1.41 |
